A new candidate for an anti-HIV-1 agent: modified cyclodextrin sulfate (mCDS71).
Moriya
T
T
Research Laboratory of Applied Biochemistry, Tanabe Seiyaku Co., Ltd., Osaka, Japan.
Saito
K
K
Kurita
H
H
Matsumoto
K
K
Otake
T
T
Mori
H
H
Morimoto
M
M
Ueba
N
N
Kunita
N
N
D000818:Animals; D000998:Antiviral Agents / Q000097:blood / Q000138:chemical synthesis* / Q000494:pharmacology; D001798:Blood Proteins / Q000378:metabolism; D002240:Carbohydrate Sequence; D002460:Cell Line; D002470:Cell Survival / Q000187:drug effects; D003505:Cyclodextrins / Q000097:blood / Q000138:chemical synthesis* / Q000494:pharmacology; D003588:Cytopathogenic Effect, Viral / Q000187:drug effects; D015195:Drug Design; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D051379:Mice; D008969:Molecular Sequence Data; D011485:Protein Binding; D051381:Rats; D013329:Structure-Activity Relationship
D000998:Antiviral Agents; D001798:Blood Proteins; D003505:Cyclodextrins